Creation/implementation of clinically relevant high-grade glioma mouse models for optimizing chemotherapeutic treatment

被引：0
|
作者：
de Vries, N. A. [1 ]
机构：
[1] Netherlands Canc Inst, Amsterdam, Netherlands
来源：
FEBS JOURNAL | 2007年 / 274卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：147 / 147
页数：1
相关论文
共 50 条
  • [1] CHARACTERIZATION OF SPONTANEOUS CANINE HIGH-GRADE GLIOMA MODELS AS CLINICALLY-RELEVANT SURROGATES OF PEDIATRIC HIGH-GRADE GLIOMA
    Link, Gabrielle
    Garey, Simon
    DeSisto, John
    Antonakakis, Markos
    McGrath, Stephanie
    Chow, Lyndah
    Slade, Mathew
    Dow, Steven
    Green, Adam L.
    [J]. NEURO-ONCOLOGY, 2024, 26
  • [2] PI3K-mTOR Pathway Inhibition Exhibits Efficacy Against High-grade Glioma in Clinically Relevant Mouse Models
    Lin, Fan
    de Gooijer, Mark C.
    Hanekamp, Diana
    Chandrasekaran, Gayathri
    Buil, Levi C. M.
    Thota, Nishita
    Sparidans, Rolf W.
    Beijnen, Jos H.
    Wurdinger, Tom
    van Tellingen, Olaf
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (05) : 1286 - 1298
  • [3] High-grade glioma mouse models and their applicability for preclinical testing
    de Vries, Nienke A.
    Beijnen, Jos H.
    van Tellingen, Olaf
    [J]. CANCER TREATMENT REVIEWS, 2009, 35 (08) : 714 - 723
  • [4] OPTIMIZING MDM2 INHIBITION FOR THE TREATMENT OF HIGH-GRADE GLIOMA
    Rendo, Veronica
    Lupien, Leslie
    Khuu, Nicholas
    Pelton, Kristine
    Elcavage, Lara
    Lu, Sophie
    Khadka, Prasidda
    Langhnoja, Jaldeep
    Phoenix, Tim
    Ligon, Keith
    Bandopadhayay, Pratiti
    Beroukhim, Rameen
    [J]. NEURO-ONCOLOGY, 2021, 23 : 77 - 77
  • [5] Treatment of high-grade glioma in children
    Betul Cakir, Fatma
    Kebudi, Rejin
    [J]. TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2013, 28 (01): : 44 - 50
  • [6] Bevacizumab for the treatment of high-grade glioma
    Khasraw, Mustafa
    Simeonovic, Marcelle
    Grommes, Christian
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (08) : 1101 - 1111
  • [7] IS HYPOPITUITARISM CLINICALLY RELEVANT IN GLIOMA PATIENTS? - A CROSS-SELECTIONAL TRIAL IN PATIENTS WITH HIGH-GRADE GLIOMAS
    Handisurya, Ammon
    Ristl, Robin
    Henzl, Harald
    Kautzky-Willer, Alexandra
    Dieckmann, Karin
    Hainfellner, Johannes
    Woehrer, Adelheid
    Preusser, Matthias
    Marosi, Christine
    [J]. NEURO-ONCOLOGY, 2014, 16
  • [8] Safety and efficacy of a novel cannabinoid chemotherapeutic, KM-233, for the treatment of high-grade glioma
    Christopher Duntsch
    Murali Krishna Divi
    Terreia Jones
    Qihong Zhou
    Mathangi Krishnamurthy
    Peter Boehm
    George Wood
    Allen Sills
    Bob M. Moore II
    [J]. Journal of Neuro-Oncology, 2006, 77 : 143 - 152
  • [9] Safety and efficacy of a novel cannabinoid chemotherapeutic, KM-233, for the treatment of high-grade glioma
    Duntsch, Christopher
    Divi, Murali Krishna
    Jones, Terreia
    Zhou, Qihong
    Krishnamurthy, Mathangi
    Boehm, Peter
    Wood, George
    Sills, Allen
    Moore, Bob M., II
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2006, 77 (02) : 143 - 152
  • [10] Treatment of high-grade glioma in children and adolescents
    MacDonald, T. J.
    Aguilera, D.
    Kramm, C. M.
    [J]. NEURO-ONCOLOGY, 2011, 13 (10) : 1049 - 1058
12345